首页 | 官方网站   微博 | 高级检索  
     

药物干预近视眼发生发展的研究现状
引用本文:王甜甜,张荣荣,吴昌凡. 药物干预近视眼发生发展的研究现状[J]. 金属学报, 2021, 26(7): 808-813. DOI: 10.12092/j.issn.1009-2501.2021.07.013
作者姓名:王甜甜  张荣荣  吴昌凡
作者单位:1.皖南医学院弋矶山医院眼科,芜湖 241001,安徽;;2.马鞍山十七冶医院眼科,马鞍山 243000,安徽
基金项目:安徽省卫生健康委科研项目(AHWJ2021b120)
摘    要:近视是儿童及青少年最为常见的眼部疾病。随着近视和高度近视的患病率逐年增加,高度近视及其并发症所导致的低视力及致盲的人数也逐渐增加。但近视的发生和发病机理目前并不清楚,现有的干预方法有光学和药物等措施。本文旨在总结近年来在临床和动物试验期方面讨论药物干预近视的研究进展。

收稿时间:2021-03-30
修稿时间:2021-04-09

Current research of drug interventions in the occurrence and development of myopia
WANG Tiantian,ZHANG Rongrong,WU Changfan. Current research of drug interventions in the occurrence and development of myopia[J]. Acta Metallurgica Sinica, 2021, 26(7): 808-813. DOI: 10.12092/j.issn.1009-2501.2021.07.013
Authors:WANG Tiantian  ZHANG Rongrong  WU Changfan
Affiliation:1. Department of Ophthalmology, Yijishan Hospital of Wannan Medical College, Wuhu 241001, Anhui, China
Abstract:Myopia is the most common eye disease occurring in children and adolescents. As the prevalence rates of myopia and high myopia have increased yearly, the number of individuals with low vision and blindness caused by high myopia and its complications has gradually increased. However, the mechanisms underlying the occurrence and development of myopia are currently unclear. The existing intervention methods include optical and drug measures. This article summarizes the measures implemented for the prevention and control of myopia in recent years and discusses the research progress of drug interventions for myopia, considering the aspects of clinical and animal trials.
Keywords:myopia   drug interventions   clinical and animal trials  
点击此处可从《金属学报》浏览原始摘要信息
点击此处可从《金属学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号